Vedana Therapeutics | RoundOS

Weekly digest by email

Loading companies…

Vedana Therapeutics | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Jun 17, 2026	Series A	$46M	Alexandria Venture Investments — Role not disclosedCanaan Partners — Role not disclosedDawn Biopharma — Role not disclosedWestlake BioPartners — Role not disclosed

Investors

Alexandria Venture InvestmentsSeries A Canaan PartnersSeries A Dawn BiopharmaSeries A Westlake BioPartnersSeries A

Coverage

Jun 17, 2026Vedana Therapeutics · Series A

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

Sources

vedanatx.com ↗